Brain metabolism scan using deuterated glucose for glioma patients
Treatments studied
Part of Cancer clinical trials.
This study uses a special sugar drink (deuterated glucose) and an MRI-like scan to measure brain metabolism. It aims to better understand how brain tumors use energy, which could help with treatment decisions in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You either have a confirmed glioma with an active tumor (seen on a previous MRI) or you are a healthy volunteer.
- You are not pregnant or breastfeeding, and you agree to use effective birth control if you could become pregnant.
- You do not have diabetes or a history of diabetes.
- Your fasting blood sugar is within normal limits (under 120 mg/dL).
- You can lie still for the scan and do not have metal implants or severe claustrophobia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests a new type of MRI scan using a special “hyperpolarized” imaging agent to help doctors diagnose glioma (a type of brain tumor). It’s mainly focused on whether the scan can safely and clearly show tumor-related information in people who may need treatment.
This early study (Phase 1) tests a new kind of MRI that uses a special labeled sugar (pyruvate) to help learn how infiltrating gliomas behave in the brain. If you have a suspected or known infiltrating glioma and are having brain surgery or biopsy, this may help your doctors learn more about tumor metabolism and guide future care.
This trial uses a special MRI scan to study the genetics of gliomas (a type of brain tumor). It may help doctors better understand your tumor and choose the right treatment. You can join if you have a suspected or confirmed low- or high-grade glioma that still has a measurable tumor after surgery.
This study uses MRI scans to find higher-risk areas in certain brain and other solid tumors and help plan radiation treatment. It also looks for changes in tumor “metabolites” (chemicals in the tumor) that may relate to how the tumor behaves.
This study looks at how brain tumors look on MRI and what biopsy tissue shows, using samples taken during planned surgery. It may help improve understanding of tumor biology and future treatment planning.
This Phase 1 study uses special MRI scans (including a form of MR spectroscopy) to better understand lower-grade gliomas. It is designed to test how well the imaging can “characterize” the tumor and to improve understanding for treatment planning.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.